Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• DNA double-strand breaks (DSBs) are critical DNA lesions threatening genome integrity.
• DSBs are key targets for radiotherapy and chemotherapy efficacy.
• DSB repair involves complex signaling cascades, including ubiquitination.

Purpose of the Study:

• To investigate the role of OTUB1 in DNA double-strand break (DSB) repair.
• To elucidate the mechanism by which OTUB1 regulates DSB-induced ubiquitination.
• To explore the therapeutic potential of targeting the OTUB1-UBC13 interaction.

Main Methods:

• Biochemical assays to study deubiquitinating enzyme activity.
• Ubiquitination assays to assess chromatin modification.
• Protein-protein interaction studies (e.g., co-immunoprecipitation).
• Cellular assays to evaluate DNA damage repair and signaling.

Main Results:

• OTUB1 acts as an inhibitor of DSB-induced chromatin ubiquitination.
• OTUB1 suppresses RNF168-dependent poly-ubiquitination independent of its catalytic activity.
• OTUB1 inhibits UBC13 (UBE2N), the E2 enzyme for RNF168, by direct binding.
• OTUB1 also interacts with other E2 enzymes (UBE2D, UBE2E subfamilies).
• Depletion of OTUB1 ameliorates DSB repair defects.

Conclusions:

• OTUB1 regulates DSB repair through a novel mechanism involving inhibition of E2 enzymes, particularly UBC13.
• This catalytic-independent inhibition highlights a unique regulatory pathway in DNA damage response.
• Targeting the OTUB1-UBC13 interaction presents a potential strategy to enhance cancer treatment efficacy.